The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 9,701–9,800 of 31,469
Frithioff‐Bøjsøe, C., Lund, M. A. V., Kloppenborg, J. T., Nielsen, T., Fonvig, C. E., Lausten‐Thomsen, U., Hedley, P. L., Hansen, T., Pedersen, O. B., Christiansen, M., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12859 · Cited by 37
Zhao, J., Huang, J., Geng, X., Chu, W., Li, S., Chen, Z., & Du, Y. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00772 · Cited by 37
Branco, B. H. M., Valladares, D., de Oliveira, F. M., Carvalho, I. Z., Marques, D. C. D. S., Coelho, A. A., de Oliveira, L. P., & Bertolini, S. M. M. G. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01013 · Cited by 37
Gorgey, A. S., Khalil, R. E., Davis, J. C., Carter, W., Gill, R. S., Rivers, J. F., Khan, R., Goetz, L. L., Castillo, T. A., Lavis, T. D., et al. (2019) · Trials · doi:10.1186/s13063-019-3560-8 · Cited by 37
Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
Wattacheril, J. J. (2019) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.10.002 · Cited by 37
Irisin levels in genetic and essential obesity: clues for a potential dual role
Mai, S., Grugni, G., Mele, C., Vietti, R., Vigna, L., Sartório, A., Aimaretti, G., Scacchi, M., & Marzullo, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-57855-5 · Cited by 39
Cardoso, N. S., Ribeiro, V. B., Dutra, S. G. V., Ferriani, R. A., Gastaldi, A. C., de Araújo, J. E., & de Souza, H. C. D. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000197 · Cited by 39
Moradi, A., Tarrahi, M. J., Ghasempour, S., Shafiepour, M., Clark, C. C. T., & Safavi, S. M. (2020) · Phytotherapy Research · doi:10.1002/ptr.6782 · Cited by 37
Zhang, Z., Kang, X., Guo, Y., Zhang, J., Xie, J., Shao, S., Xiang, Y., Chen, G., & Yu, X. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13088 · Cited by 37
Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia
Mednova, I. A., Boiko, A. S., Kornetova, E. G., Parshukova, D. A., Semke, A. V., Bokhan, N. A., LOONEN, A. J. M., & Ivanova, S. А. (2020) · Metabolites · doi:10.3390/metabo10100410 · Cited by 37
Frey, S., Mirallié, É., Cariou, B., & Blanchard, C. L. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.12.029 · Cited by 37
Toshimitsu, T., Gotou, A., Sashihara, T., Furuichi, K., Hachimura, S., Shioya, N., Suzuki, S., & Asami, Y. (2021) · Current Developments in Nutrition · doi:10.1093/cdn/nzab006 · Cited by 37
Saito, N., Furuhashi, M., Koyama, M., Higashiura, Y., Akasaka, H., Tanaka, M., Moniwa, N., Ohnishi, H., Saitoh, S., Ura, N., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83494-5 · Cited by 37
Trim, W. V., Walhin, J., Koumanov, F., Bouloumié, A., Lindsay, M. A., Chen, Y., Travers, R. L., Turner, J. E., & Thompson, D. (2021) · The Journal of Physiology · doi:10.1113/jp280977 · Cited by 41
Sadashiv, Modi, A., Khokhar, M., Sharma, P., Joshi, R. P., Mishra, S. S., Bharshankar, R. N., Tiwari, S., Singh, P. K., Bhosale, V. V., et al. (2021) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes20131 · Cited by 39
Distribution of HOMA-IR in a population-based cohort and proposal for reference intervals
Matli, B., Schulz, A., Koeck, T., Falter, T., Lotz, J., Rossmann, H., Pfeiffer, N., Beutel, M. E., Münzel, T. F., Strauch, K., et al. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0643 · Cited by 37
Zhu, C., Huang, D., Ma, H., Qian, C., You, H., Bu, L., & Qu, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.848937 · Cited by 40
Driuchina, A., Hintikka, J. E., Lehtonen, M., Keski‐Rahkonen, P., O’Connell, T. M., Juvonen, R. O., Kuula, J., Hakkarainen, A., Laukkanen, J. A., Mäkinen, E., et al. (2023) · mBio · doi:10.1128/mbio.02663-22 · Cited by 39
Share, B. L., Naughton, G. A., Obert, P., Peat, J. K., Aumand, E. A., & Kemp, J. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130270 · Cited by 37
Low-dose steroids associated with milder histological changes after pediatric liver transplantation
Kosola, S. K., Lampela, H., Jalanko, H., et al. (2012) · Liver Transplantation · doi:10.1002/lt.23565 · Cited by 37
Hannan-Jones, M. T., & Capra, S. M. (2015) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2015.100 · Cited by 37
Suzuki, K., Kirikoshi, H., Yoneda, M., Mawatari, H., Fujita, K., Nozaki, Y., Takahashi, H., Abe, Y., Inamori, M., Shimamura, T., et al. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00643.x · Cited by 37
de Carvalho, T. M. R., Marin, D. M., da Silva, C. A., de Souza, A. L., Talamoni, M., Lima, C. S. P., & Alegre, S. M. (2013) · Head & Neck · doi:10.1002/hed.23568 · Cited by 36
Decreased Plasma Apelin Levels in Pubertal Obese Children
Tapan, S., Taşçılar, E., Abacı, A., Sönmez, A., Kılıç, S., Erbil, M. K., & Özcan, O. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.165 · Cited by 37
Mitterberger, M. C., Mattesich, M., Klaver, E., Lechner, S., Engelhardt, T. O., Larcher, L., Pierer, G., Piza‐Katzer, H., & Zwerschke, W. (2010) · The Journals of Gerontology Series A · doi:10.1093/gerona/glq107 · Cited by 37
Tsekouras, Y. E., Magkos, F., Prentzas, K. I., Basioukas, K. N., Matsama, S. G., Yanni, A. E., Kavouras, S. A., & Sidossis, L. S. (2008) · Clinical Science · doi:10.1042/cs20080078 · Cited by 37
Lind, L., Andersson, J., Rönn, M., et al. (2007) · Lipids · doi:10.1007/s11745-007-3125-6 · Cited by 37
Abete, I., Parra, D., de Morentin, B. E. M., & Martínez, J. A. (2008) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637480802232625 · Cited by 38
Tokunaga, A., Miura, A., Okauchi, Y., SEGAWA, K., Fukuhara, A., Okita, K., Takahashi, M., Funahashi, T., Miyagawa, J.-I., Shimomura, I., et al. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-039 · Cited by 37
Bezafibrate Improves Hypertension and Insulin Sensitivity in Humans
Kim, J., Tsujino, T., Fujioka, Y., Saito, K., & Yokoyama, M. (2003) · Hypertension Research · doi:10.1291/hypres.26.307 · Cited by 37
Relationship between birthweight and arterial elasticity in childhood
Rondó, P. H. D. C., Lemos, J. O., Pereira, J. A., de Oliveira, J. M., & Innocente, L. R. (2008) · Clinical Science · doi:10.1042/cs20070420 · Cited by 37
Metabolic Syndrome and Insulin Resistance in Subjects with Morbid Obesity
Soverini, V., Moscatiello, S., Villanova, N., Ragni, E., Domizio, S. D., & Marchesini, G. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9999-z · Cited by 37
Hypomagnesemia, Insulin Resistance, and Non-Alcoholic Steatohepatitis in Obese Subjects
Rodríguez-Hernández, H., González, J. L., Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.03.008 · Cited by 36
Aasen, G., Fagertun, H., & Halse, J. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510701649524 · Cited by 37
Corripio, R., González-Clemente, J. M., Pérez, J., Näf, S., Gallart, L., Joan, V., & Caixàs, A. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04431.x · Cited by 37
Paramsothy, P., Knopp, R. H., Bertoni, A. G., Tsai, M. Y., Rue, T. C., & Heckbert, S. R. (2009) · Metabolism · doi:10.1016/j.metabol.2008.09.016 · Cited by 38
Pardina, E., López-Tejero, M. D., Llamas, R., Catalán, R., Galard, R., Allende, H., Vargas, V., Lecube, A., Fort, J. M., Baena‐Fustegueras, J. A., et al. (2009) · Obesity Surgery · doi:10.1007/s11695-008-9793-3 · Cited by 37
Buschard, K., Fredman, P., Bøg‐Hansen, E., Blomqvist, M., Hedner, J. A., Råstam, L., & Lindblad, U. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01613.x · Cited by 37
Arslan, M. S., Şahi̇n, M., Topaloğlu, O., et al. (2013) · Clinical Endocrinology · doi:10.1111/cen.12217 · Cited by 37
Yılmaz, M. İ., Sönmez, A., Çağlar, K., Gök, D. E., Eyileten, T., Yenicesu, M., Açıkel, C., Bingöl, N., Kılıç, S., Oğuz, Y., et al. (2004) · Endocrine · doi:10.1385/endo:25:3:207 · Cited by 35
Stranges, S., Rafalson, L. B., Dmochowski, J., Rejman, K., Tracy, R. P., Trevisan, M., & Donahue, R. P. (2008) · Obesity · doi:10.1038/oby.2008.59 · Cited by 37
Cizmecioglu, P. M., Etiler, N., Hamzaoğlu, O., & Hatun, Ş. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.8.703 · Cited by 37
Effect of recombinant human erythropoietin on insulin resistance in hemodialysis patients
Khedr, E., Elsharkawy, M. M., ABDULWAHAB, S., et al. (2009) · Hemodialysis International · doi:10.1111/j.1542-4758.2009.00367.x · Cited by 37
Dickie, K., Micklesfield, L. K., Chantler, S., Lambert, E. V., & Goedecke, J. H. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-498 · Cited by 37
Eriksen, M., Jensen, D. H., Tribler, S., Holst, J. J., Madsbad, S., & Krarup, T. (2015) · Diabetologia · doi:10.1007/s00125-015-3522-y · Cited by 35
Reduced insulin secretion in normoglycaemic patients with β‐thalassaemia major
Angelopoulos, N., Zervas, A., Livadas, S., et al. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01988.x · Cited by 37
Yoshida, T., Kaneshi, T., Shimabukuro, T., Sunagawa, M., & Ohta, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2856 · Cited by 37
DeBoer, M. D., & Gurka, M. J. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0008 · Cited by 37
Perticone, F., Sciacqua, A., Scozzafava, A., Ventura, G., Laratta, E., Pujia, A., Federici, M., Lauro, R., & Sesti, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032161 · Cited by 37
Erdem, G., Doğru, T., Taşçı, İ., Bozoğlu, E., Muhsiroğlu, Ö., Tapan, S., Erçin, C. N., & Sönmez, A. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.07.021 · Cited by 35
Ito, K., Nakatani, K., Fujii, M., Katsuki, A., Tsuchihashi, K., Murata, K., Goto, H., Yano, Y., Gabazza, E. C., Sumida, Y., et al. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00034.x · Cited by 38
Li, J., Tian, H., Li, Q., Wang, N., Wu, T., Liu, Y., Ni, Z., Yu, H., Liang, J., Luo, R., et al. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00638.x · Cited by 37
Sharma, B. C., Kumar, A., Garg, V., Reddy, R. S. L., Sakhuja, P., & Sarin, S. K. (2012) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2012.10.010 · Cited by 37
Heald, A. H., Sharma, R., Anderson, S. G., Vyas, A., Siddals, K. W., Patel, J. V., Bhatnagar, D., Prabharkaran, D., Rudenski, A. S., Hughes, E. A., et al. (2005) · Public Health Nutrition · doi:10.1079/phn2005729 · Cited by 37
Self-citationAriel, D., Kim, S. H., Abbasi, F., Lamendola, C. A., Liu, A., & Reaven, G. M. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.06.010 · Cited by 37
Miranda, J., Aguirre, L., Fernández‐Quintela, A., Macarulla, M. T., Martínez-Castaño, M. G., Ayo, J., Bilbao, E., & Portillo, M. P. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf305076v · Cited by 37
Fowler, S. P., Puppala, S., Arya, R., Chittoor, G., Farook, V. S., Schneider, J. L., Resendez, R. G., Upadhayay, R. P., VandeBerg, J. F., Hunt, K. J., et al. (2013) · Human Genetics · doi:10.1007/s00439-013-1315-2 · Cited by 36
Lőrincz, H., Katkó, M., Harangi, M., Somodi, S., Gaál, K., Fülöp, P., Paragh, G., & Seres, I. (2013) · Clinical Endocrinology · doi:10.1111/cen.12363 · Cited by 37
Shertzer, H. G., Kendig, E. L., Nasrallah, H. A., Johansson, E., & Genter, M. B. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.291 · Cited by 39
Li, Y., Han, T.-T., Liu, Y., Zheng, S., Zhang, Y., Liu, W., & Hu, Y. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.020 · Cited by 37
Larrieta‐Carrasco, E., León‐Mimila, P., Villarreal-Molina, M. T., Villamil‐Ramírez, H., Romero‐Hidalgo, S., Jacobo‐Albavera, L., Gutiérrez‐Vidal, R., López-Contreras, B. E., Guillén-Pineda, L. E., Sánchez‐Muñoz, F., et al. (2013) · Gene · doi:10.1016/j.gene.2013.03.038 · Cited by 38
Yılmaz, M. İ., Qureshi, A. R., Carrero, J. J., et al. (2009) · American Journal of Nephrology · doi:10.1159/000272936 · Cited by 37
Zhang, Q., Tan, Y., Zhang, N., & Yao, F. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2708 · Cited by 38
Lobley, G. E., Holtrop, G., Bremner, D. M., Calder, A. G., Milne, E., & Johnstone, A. M. (2013) · Nutrients · doi:10.3390/nu5062144 · Cited by 38
Nakanishi, S., Yamane, K., Kamei, N., et al. (2003) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00313.x · Cited by 37
Sun, D., Wang, K., Yan, Z., Zhang, G., Liu, S., Liu, F., Hu, C.-X., & Hu, S. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0985-0 · Cited by 37
Subclinical Coronary Atherosclerosis in Asymptomatic Filipino and White Women
Araneta, M. R. G., & Barrett-Connor, E. L. (2004) · Circulation · doi:10.1161/01.cir.0000146377.15057.cc · Cited by 37
The effect of carbohydrate availability following exercise on whole-body insulin action
Holtz, K. A., Stephens, B. R., Sharoff, C. G., Chipkin, S. R., & Braun, B. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-077 · Cited by 37
Prevalence of diabetes mellitus in Croatia
Metelko, Ž., Pavlić-Renar, I., Poljičanin, T., Szirovitza, L., & Turek, S. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.04.016 · Cited by 37
Insulin sensitivity is impaired in adults with varying degrees of GH deficiency
Murray, R. D., & Shalet, S. M. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02194.x · Cited by 37
Meijssen, S., Cabezas, M. C., Ballieux, C. G. M., Derksen, R. J., Bilecen, S., & Erkelens, D. W. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7794 · Cited by 37
Circulating ghrelin/obestatin ratio in subjects with Helicobacter pylori infection
Gao, X., Kuang, H., Liu, X.-M., et al. (2009) · Nutrition · doi:10.1016/j.nut.2008.11.002 · Cited by 37
Utz, A. L., Yamamoto, A., Sluss, P. M., Breu, J. J., & Miller, K. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0930 · Cited by 37
Impaired β‐cell function in lean normotolerant former gestational diabetic women
Tura, A., Mari, A., Winzer, C., Kautzky‐Willer, A., & Pacini, G. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01587.x · Cited by 37
Iwata, M., Matsushita, Y., Fukuda, K., Wakura, T., Okabe, K., Koshimizu, Y., Fukushima, Y., Kobashi, C., Yamazaki, Y., Honoki, H., et al. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12181 · Cited by 37
Hacıhamdioğlu, B., Okutan, V., Yozgat, Y., Yıldırım, D., Kocaoğlu, M., Lenk, M. K., & Özcan, O. (2011) · PubMed · Cited by 37
Lindgärde, F., Widén, I., Gebb, M., & Åhrén, B. (2004) · Metabolism · doi:10.1016/j.metabol.2004.04.012 · Cited by 37
Goff, L. M., Griffin, B. A., Lovegrove, J. A., Sanders, T. A. B., Jebb, S. A., Bluck, L. J. C., Frost, G. S., & on behalf of the RISCK Study Group (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112467545 · Cited by 37
Reproducibility of S-insulin and B-glucose responses in two identical oral glucose tolerance tests
Schousboe, K., Henriksen, J. E., Kyvik, K. O., Sørensen, T. I. A., & Petersen, P. H. (2002) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655102764654358 · Cited by 36
Visceral and Subcutaneous Adiposity and Adiponectin in Middle‐aged Japanese Men: The ERA JUMP Study
Nakamura, Y., Sekikawa, A. M., Kadowaki, T., Kadota, A., Kadowaki, S., Maegawa, H., Kita, Y., Evans, R. G., Edmundowicz, D., Curb, J. D., et al. (2009) · Obesity · doi:10.1038/oby.2009.3 · Cited by 38
Hwang, Y., Ahn, H. Y., Park, H., & Park, C. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0195 · Cited by 37
Fabbrini, E., Magkos, F., Conte, C., Mittendorfer, B., Patterson, B. W., Okunade, A. L., & Klein, S. (2011) · Journal of Lipid Research · doi:10.1194/jlr.d020321 · Cited by 37
Glucose tolerance of premenopausal women after menopause due to surgical removal of ovaries
Pirimoğlu, Z. M., Arslan, C., Büyükbayrak, E. E., Kars, B., Karsidag, Y. K., Ünal, O., & Turan, M. C. (2011) · Climacteric · doi:10.3109/13697137.2010.539723 · Cited by 37
Martins, C. J. D. M., Genelhu, V. A., Pimentel, M. M. G., Celoria, B. M. J., Mangia, R. F., Aveta, T., Silvestri, C., Marzo, V. D., & Francischetti, E. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142728 · Cited by 37
Savic-Radojevic, A. R., Antić, I. B., Coric, V. M., Bjekić-Macut, J., Radic, T. M., Žarković, M., Djukic, T. I., Pljesa-Ercegovac, M. S., Panidis, D., Katsikis, I., et al. (2014) · HORMONES · doi:10.14310/horm.2002.1525 · Cited by 39
Kadkhodayan, A., Lin, C. H., Coggan, A. R., Kisrieva-Ware, Z., Schechtman, K. B., Novak, E. L., Joseph, S. M., Dávila‐Román, V. G., Gropler, R. J., Dence, C. S., et al. (2016) · Journal of Nuclear Cardiology · doi:10.1007/s12350-016-0467-6 · Cited by 38
Eucaloric Ketogenic Diet Reduces Hypoglycemia and Inflammation in Mice with Endotoxemia
Nandivada, P., Fell, G. L., Pan, A., Nosé, V., Ling, P., Bistrian, B. R., & Puder, M. (2016) · Lipids · doi:10.1007/s11745-016-4156-7 · Cited by 39
Metabolic Syndrome and Cardiovascular Risk in HIV-Infected Patients with Lipodystrophy
Falasca, K., Ucciferri, C., Manzoli, L., Mancino, P., Pizzigallo, E., Conti, P., & Vecchiet, J. (2007) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200702000310 · Cited by 36
Ramírez, N. R., Toledo, R. C. L., Moreira, M. E. D. C., Martino, H. S. D., Benjamin, L. D. A., de Queiróz, J. H., Ribeiro, A. Q., & Ribeiro, S. M. R. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.015 · Cited by 39
Intermittent Standing but not a Moderate Exercise Bout Reduces Postprandial Glycemia
Benatti, F. B., Larsen, S. A., KOFOED, K., Nielsen, S. T., Harder-Lauridsen, N. M., Lyngbæk, M. P. P., Eriksen, D., Karstoft, K., Krogh‐Madsen, R., Pedersen, B. K., et al. (2017) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001354 · Cited by 40
Cortés, V., Quezada, N., Uribe, S. A., Arrese, M. A., & Nervi, F. O. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0525-3 · Cited by 37
Chylomicron-Derived Fatty Acid Spillover in Adipose Tissue: A Signature of Metabolic Health?
Piché, M., Parry, S. A., Karpe, F., & Hodson, L. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01517 · Cited by 37
Fawzy, M. S., & Alsel, B. T. A. (2018) · Journal of Diabetes Research · doi:10.1155/2018/8517929 · Cited by 37
Zhou, H., Fang, C., Zhang, L., et al. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20131917 · Cited by 37
Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults
Qi, J.-C., Huang, J., Lin, Q., Zhao, J., Lin, X., Chen, L., Huang, J., & Chen, X. (2015) · Sleep And Breathing · doi:10.1007/s11325-015-1232-9 · Cited by 37
Kipfer-Coudreau, S., Eberlé, D., Sahbatou, M., Bonhomme, A., Guy-grand, B., Froguel, P., Galan, P., Basdevant, A., & Clément, K. (2004) · Diabetologia · doi:10.1007/s00125-004-1432-5 · Cited by 37
Meshkani, R., Taghikhani, M., Larijani, B. A., Khatami, S., Khoshbin, E., & Adeli, K. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.03.018 · Cited by 37
Lee, C.-H., Kuo, S., Hung, Y., Hsieh, C., He, C., Yang, T., Lian, W., Fan, S. C., & Pei, D. (2005) · Endocrine Research · doi:10.1080/07435800500320653 · Cited by 37
López‐Bermejo, A., Casano, P., Fernández‐Real, J. M., Kihara, S., Funahashi, T., Rodríguez‐Hierro, F., Ricart, W., & Ibáñez, L. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02102.x · Cited by 37
Wu, D., Chu, N., Shen, M., & Wang, S.-C. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.05.007 · Cited by 37
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
